Sarcoma  >>  Votrient (pazopanib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Votrient (pazopanib) / Novartis, BeiGene
NCT01012362: Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Checkmark Data-AACR
Mar 2012 - Mar 2012: Data-AACR
Terminated
1
31
US
Pazopanib, Pazopanib hydrochloride, GW786034B, Ixabepilone, IXEMPRA(TM)
Masonic Cancer Center, University of Minnesota, GlaxoSmithKline
Breast Cancer, Lung Cancer, Colon Cancer, Pancreatic Cancer, Head and Neck Cancer, Kidney Cancer, Sarcoma, Hepatocellular Cancer
02/13
02/13
PASART-1, NCT01985295: Combined Modality Treatment of Sarcomas of the Extremities

Completed
1
12
Europe
pazopanib, Compound Number: GW786034
The Netherlands Cancer Institute, GlaxoSmithKline
Sarcoma,Soft Tissue
08/14
11/14
NCT01438554: Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark AACR-NCI-EORTC 2013
Oct 2013 - Oct 2013: AACR-NCI-EORTC 2013
Checkmark P1 data-ASCO
More
Completed
1
89
US
Pazopanib, Votrient, GSK1120212, Trametinib, Mekinist
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Comprehensive Cancer Network, Novartis
Solid Tumors, Thyroid Cancer, Soft-tissue Sarcoma, Cholangiocarcinoma
04/16
08/18
NCT03139331: PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma

Completed
1
16
US
Pazopanib, Irinotecan, Temozolomide
University of California, San Francisco, UCSF Benioff Children's Hospital Oakland, Dana-Farber Cancer Institute, Alex's Lemonade Stand Foundation
Sarcoma, Refractory Sarcoma
10/19
09/20
NCT01543763: Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

Checkmark ASCO 2016
May 2016 - May 2016: ASCO 2016
Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2014
More
Active, not recruiting
1
90
US
PZP115891, PCI-24781, abexinostat, S 78454, GW786034, Votrient™, Pazopanib
Pamela Munster, Pharmacyclics LLC., Novartis, Xynomic Pharmaceuticals, Inc., GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease
Metastatic Solid Tumors
01/24
12/24

Download Options